An analysis of more than 13 million EHR notes revealed evidence suggesting racial bias in how doctors document patient credibility.

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ifinatamab deruxtecan (I-DXd) for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC ...